A Study of EXG102-031 in Patients With wAMD (Everest)

Clinical trial NCT05903794 · COMPLETED

Trial details

NCT number: NCT05903794
Sponsor: Exegenesis Bio
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neovascular (Wet) Age-related Macular Degeneration (nAMD)

Start date: 2023-07-24
Primary completion: 2026-02-16
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.